Experience

Discovery Life Sciences

• United States
• Biotechnology Research
• 300 - 400 Employee

• Vice President for Business Development - Government & Non-profit Research

  • Feb 2023 - Present

  Build and Manage a Business Unit focused on delivering Discovery Life Science's highly competitive core products, services and capabilities in Genomics, Proteomics, Biospecimens, Biomarkers, & Cell Biology to Government and Non-Profit Research Institutes. Build and Manage a Business Unit focused on delivering Discovery Life Science's highly competitive core products, services and capabilities in Genomics, Proteomics, Biospecimens, Biomarkers, & Cell Biology to Government and Non-Profit Research Institutes.



Illumina

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Microbial and Infectious Disease Specialist

  • Jun 2021 - Feb 2023

  Dr. Detter provides thought leadership, strategic direction, market & business development, effective solutions, and subject matter expertise to help customers within the microbial markets and related segments (including, but not limited to microbial identification, metagenomics, infectious disease, food testing and public health). In doing so, Dr. Detter regularly works closely with other functional roles and teammates under the Illumina team-selling model that includes account managers, district sales managers, inside sales, and marketing teams. Additionally, Dr. Detter helps ensure voice of customer input is proactively and effectively communicated across relevant teams to help drive product development plans and roadmaps. Show less



Latham BioPharm Group, part of Sia Partners

• United States
• Business Consulting and Services
• 1 - 100 Employee

• Principal Consultant, Medical Devices & Diagnostics, LBG; CSO (acting), Definitive Biotechnologies

  • Apr 2020 - Feb 2023

  Dr. Detter is a seasoned molecular and microbiologist that has spent more than 20 years technically and strategically leading highly effective teams in the areas of Global Health, Agriculture Health, and Biosecurity. Chris is currently a Principal Consultant at Latham BioPharm Group where he provides effective solutions and subject matter expertise to help clients acquire funding, build business, manage contracts, manage programs, and drive innovation. Additionally, Dr. Detter serves as acting CSO for Definitive Biotechnologies, LLC (a subsidiary of Latham BioPharm Group) that serves to license new diagnostic technologies and rapidly take them to market. Dr. Detter’s role is to lead both the rapid applied development from the technical side and many of the collaborative engagements from the business development side to rapidly move a hand-held infectious disease diagnostic device from the lab, through the FDA and to the market as a POC and OTC at-home application. Chris has authored more than 100 peer reviewed publications on these topic areas. He has scoped, trained, and assisted in setting up genome centers worldwide (including Hawaii, Republic of Georgia, Thailand, Malaysia, and Africa). He has served as a scientific subject matter expert for several law firms and has served on Science Advisory Boards and Board of Directors for Fortune 500 companies, smaller startups and US National Laboratories. Chris is also the founder and lead organizer of the annual Sequencing, Finishing, and Analysis in the Future (SFAF) Genomic Meeting that he started in 2006 to bring together a diverse set of motivated scientists from Academia, US Government, Industry and International Health Communities that are passionate about moving the field of genomics forward faster and more effectively using the rapidly evolving NGS technologies. Show less



MRIGlobal

• Florida, Maryland & Kansas City

• Chief Scientist and Research & Development Manager

  • Nov 2015 - Jan 2020



Los Alamos National Laboratory

• United States
• Research Services
• 700 & Above Employee

• Group Leader - Genomics Group

  • Sep 2005 - Nov 2015



Defense Threat Reduction Agency (DTRA)

• Fort Belvoir, VA

• Senior Science Advisor

  • Oct 2013 - Oct 2015



Lawrence Livermore National Laboratory

• United States
• Research Services
• 700 & Above Employee

• Group Leader - DOE Joint Genome Institute

  • Sep 1999 - Sep 2005